Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
1.
Dermatol Surg ; 48(1): 12-16, 2022 Jan 01.
Article in English | MEDLINE | ID: mdl-34904573

ABSTRACT

BACKGROUND: Cutaneous squamous cell carcinomas (cSCC) have upstage rates of approximately 10.3% to 11.1%. Data are currently limited on the rate of upstaging for metastatic cSCC. OBJECTIVE: The aim of this study was to determine the rates of upstaging, between diagnosis and surgery, and differences in management for metastatic and non-metastatic high-risk cSCC. MATERIALS AND METHODS: This was a retrospective, case-control, single institution, multi-center study. Univariate analysis was used. RESULTS: Sixty-eight subjects (34 metastatic & 34 non-metastatic) with 69 tumors were included. The overall rate of upstaging was 46.4%. The most common reasons for upstage were undocumented tumor size and under-diagnosis of poor differentiation. There were no differences in rates of upstaging. Preoperative imaging was performed in 43.6% of wide local excisions (WLE) versus 3.3% of Mohs micrographic surgery (MMS; p < .001). The median days from surgery to sentinel lymph node biopsy (SLNB), or nodal dissection was shorter for WLE versus MMS (0 vs 221 days, p < .001). CONCLUSION: Improved clinical documentation, including documenting tumor size, and the identification of pathologic risk factors, including poor differentiation and depth of invasion, are needed for proper staging. Preoperative imaging and discussion of SLNB may be beneficial for high-risk T2b and T3 tumors.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Mohs Surgery/statistics & numerical data , Skin Neoplasms/diagnosis , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/secondary , Carcinoma, Squamous Cell/surgery , Case-Control Studies , Female , Follow-Up Studies , Humans , Lymph Node Excision/statistics & numerical data , Male , Middle Aged , Neoplasm Staging/statistics & numerical data , Retrospective Studies , Risk Factors , Sentinel Lymph Node Biopsy/statistics & numerical data , Skin Neoplasms/pathology , Skin Neoplasms/surgery
2.
Dermatol Online J ; 27(9)2021 Sep 15.
Article in English | MEDLINE | ID: mdl-34755980

ABSTRACT

Cutaneous B cell pseudolymphoma (CBPL), or cutaneous lymphoid hyperplasia, is the most common pseudolymphoma. It typically responds well to local treatment and follows a benign course. Herein, we describe the unique case of a patient with CBPL that was refractory to a variety of treatments, with subsequent response to rituximab followed by methotrexate. This case explores the complex interplay of T and B lymphocytes, and the potential role of perifollicular T cells in treatment resistant CBPL. Further, it describes the additive therapeutic effect of rituximab and methotrexate to target both B cell and T cell populations in CBPL, a strategy already employed in a number of other conditions.


Subject(s)
Antineoplastic Agents, Immunological/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Methotrexate/administration & dosage , Pseudolymphoma/drug therapy , Rituximab/administration & dosage , Skin Neoplasms/drug therapy , Aged , B-Lymphocytes/drug effects , Drug Resistance , Humans , Male , Pseudolymphoma/immunology , Skin/immunology , Skin/pathology , T-Lymphocytes/drug effects
3.
Cancer ; 126(21): 4780-4787, 2020 11 01.
Article in English | MEDLINE | ID: mdl-32786022

ABSTRACT

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, but to the authors' knowledge, limited data exist regarding the safety and efficacy of these agents in transplant recipients. Herein, the authors have reported their experience with 17 patients who were treated with ICIs for metastatic malignancies after undergoing solid organ transplantation. METHODS: Data were abstracted for solid organ transplant recipients who received ICIs for the treatment of malignancy between January 1, 2016, and September 30, 2019. The authors identified 7 kidney, 8 liver, and 2 heart transplant recipients. Outcomes of interest were adverse drug reactions, cancer progression, and patient survival. RESULTS: The most common malignancies treated with ICIs were metastatic squamous cell carcinoma (5 patients; 29%) and hepatocellular carcinoma (5 patients; 29%), which were noted exclusively among liver transplant recipients. The median duration on ICIs was 1.7 months (interquartile range, 0.4-7.6 months). Five patients (29%) developed adverse reactions, including 4 patients (24%) with immune-related adverse events(irAEs), 3 patients (18%) with acute allograft rejections, 1 patient (6%) with autoimmune colitis, and 1 patient (6%) with ICI-induced cardiotoxicity (the patient was a heart transplant recipient). The cumulative incidence of cancer progression was 50% and 69%, respectively, at 6 months and 12 months. Eleven patients (65%) died over the median follow-up period of 4.6 months (interquartile range, 1.5-13.2 months) from the time of ICI initiation, with cancer progression being the most common cause of death. CONCLUSIONS: ICIs can be used as individualized therapy in selected patients who have undergone solid organ transplantation but more studies are needed to determine how best to use these agents to improve outcomes further.


Subject(s)
Immune Checkpoint Inhibitors/therapeutic use , Neoplasms/drug therapy , Organ Transplantation/methods , Aged , Humans , Immune Checkpoint Inhibitors/pharmacology , Middle Aged , Neoplasm Metastasis
4.
J Am Acad Dermatol ; 82(4): 846-853, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31437542

ABSTRACT

BACKGROUND: Inositol polyphosphate-5-phosphatase (INPP5A) has been shown to play a role in the progression of actinic keratosis to cutaneous squamous cell carcinoma (cSCC) and the progression of localized disease to metastatic disease. Currently, no cSCC biomarkers are able to risk stratify recurrent and metastatic disease. OBJECTIVE: To determine the prognostic value of INPP5A expression in cSCC recurrent and metastatic disease. METHODS: We conducted a multicenter, single-institutional, retrospective cohort study within the Mayo Clinic Health System on the use of immunohistochemical staining to examine cSCC INPP5A protein expression in primary tumors and recurrent and metastatic disease. Dermatologists and dermatopathologists were blinded to outcome. RESULTS: Low staining expression of INPP5A in recurrent and metastatic disease tumors was associated with poor overall survival (OS) (31.0 months for low versus 62.0 months for high expression; P = .0272). A composite risk score (calculated as score of primary tumor + score of recurrent or metastatic disease tumor, with tumors with high expression scoring a zero and low expression a 1, score range 0-2) of 0 was predictive of improved OS compared with a composite risk score of ≥1 (hazard ratio 0.42, 95% confidence interval 0.21-0.84; P = .0113). LIMITATIONS: This is a multicenter but single institution study of a white population. CONCLUSION: Loss of INPP5A expression predicts poor OS in recurrent and metastatic disease of cSCC.


Subject(s)
Carcinoma, Squamous Cell/enzymology , Inositol Polyphosphate 5-Phosphatases/genetics , Neoplasm Recurrence, Local/enzymology , Skin Neoplasms/enzymology , Aged , Biomarkers/analysis , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Disease Progression , Female , Gene Expression , Humans , Immunohistochemistry , Inositol Polyphosphate 5-Phosphatases/analysis , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/pathology , Prognosis , Retrospective Studies , Skin Neoplasms/genetics , Skin Neoplasms/pathology
5.
Pediatr Dermatol ; 37(5): 881-883, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32618378

ABSTRACT

We report a case of a 13-year-old boy with extensive lymphomatoid papulosis (LyP) involving his elbows, forearms, proximal thighs, and right hip, with treatment-resistant nodules on his right forearm. He was treated with full-body narrowband ultraviolet B and targeted photodynamic therapy (PDT) with 20% aminolevulinic acid (ALA). After two months, there was complete resolution of the right forearm nodules. Due to its minimal toxicity, PDT offers unique advantages and may be considered for pediatric LyP patients with symptomatic, localized disease resistant to conventional treatments.


Subject(s)
Lymphomatoid Papulosis , Photochemotherapy , Skin Neoplasms , Adolescent , Child , Humans , Lymphomatoid Papulosis/diagnosis , Lymphomatoid Papulosis/drug therapy , Male , Skin Neoplasms/drug therapy
6.
Telemed J E Health ; 26(7): 935-940, 2020 07.
Article in English | MEDLINE | ID: mdl-31613713

ABSTRACT

Introduction: Access to dermatologic care is a major issue in the United States, especially within the un- and underinsured populations; technology, including teledermatology, will pay a role in improving access to care. Methods: We performed a prospective study between November 2016 and September 2017. We leveraged a partnership between Mayo Clinic and Mountain Park Health Clinic, a community clinic that primarily serves un- and underinsured populations. We implemented a mobile phone-based store and forward (SAF) teledermatology service, which integrated an external community health clinic to an existing electronic health record (EHR) using standardized data capture forms, real-time support, and simple workflows. Results: Thirty-seven patients were enrolled in the study, 65% female and 35% male with an average age of 47.9 (SD = 15.9). The ethnic breakdown was: 81.1% Hispanic, 13.5% Caucasian, and 5.4% African American. The majority, 62.2%, did not have a high school education, 45.9% were unemployed, and 51.4% were uninsured. 64.9% earned less than $25,000 for annual household income. Teledermatology consultation increased the absolute diagnostic and management concordance by 36.6% (p = 0.01, 95% CI 12.2%-61.0%) and 34.2% (p < 0.01, 95% CI 11%-57%), respectively. Primary care providers had a significant increase in mean confidence in the diagnosis and management of dermatology conditions pre and poststudy (3.60 vs. 3.70 and 3.21 vs. 3.60, respectively; p < 0.01). Ninety-six percent of the primary care providers agreed (52.0%) and strongly agreed (44.0%) that they would send another patient for teleconsultation.Conclusion: We successfully implemented a SAF teledermatology consultative service in a community health clinic outside our EHR. A similar approach can be used by other large health care organizations to provide integrated, high-quality consultation to clinics with rural, un- and underinsured populations.


Subject(s)
Dermatology , Skin Diseases , Telemedicine , Female , Health Services Accessibility , Humans , Male , Middle Aged , Prospective Studies , Referral and Consultation , United States
9.
J Am Acad Dermatol ; 80(3): 626-632.e1, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30359624

ABSTRACT

BACKGROUND: Inositol polyphosphate 5-phosphatase (INPP5A) has been shown to play a role in development and progression of cutaneous squamous cell carcinoma (cSCC). The goal of the current study was to explore the prognostic value of INPP5A expression in cSCC. METHODS: A total of 189 cases of actinic keratosis and SCC in 174 patients were identified; clinical and outcome data were abstracted, histopathology was rereviewed, and immunohistochemical staining and interpretation was performed for INPP5A. RESULTS: The majority of tumors (89.4%) had an INPP5A score of 2 or 3. No patients had complete loss of INPP5A. Tumors with an INPP5A score of 1 were more likely to be intermediate- to high-risk tumors (Brigham and Women's Hospital stage ≥T2a 85.0% vs 23.7% [P < .0001]) characterized by a larger diameter (2.4 cm vs 1.3 cm [P = .0004]), moderate-to-poor differentiation (86.7% vs 17.6% [P < .0001]), and perineural invasion (37.5% vs 5.3%, [P < .0001]). An INPP5A score of 1 was associated with a worse 3-year survival (a rate of 42.3% [hazard ratio, 2.81, P = .0006]) and a local metastasis rate of 48.0% (hazard ratio, 4.71; P < .0001). CONCLUSIONS: Low INPP5A scores are predictive of aggressive tumors and may be a useful adjunct to guide clinical management of cSCC.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/secondary , Inositol Polyphosphate 5-Phosphatases/metabolism , Keratosis, Actinic/metabolism , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Aged , Aged, 80 and over , Biomarkers, Tumor/metabolism , Female , Humans , Keratosis, Actinic/pathology , Male , Middle Aged , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Metastasis , Peripheral Nerves/pathology , Prognosis , Retrospective Studies , Survival Rate , Tumor Burden
10.
Dermatol Surg ; 45(6): 811-817, 2019 06.
Article in English | MEDLINE | ID: mdl-30204735

ABSTRACT

BACKGROUND: The development of procedural skills is necessary for medical students. Computer-based video instruction (CBVI) increases knowledge and procedural skills. OBJECTIVE: This pilot study's aim was to investigate the usefulness of CBVI in dermatologic procedure training for medical students and secondarily assess students' overall perception of the field of dermatology. METHODS: Twenty-nine first- and second-year medical students were randomly assigned to the CVBI group or control group, in addition to in-person instructor demonstration of shave and punch biopsies using fresh cadaver tissue. Blinded evaluators graded student performances using a five-point Likert scale immediately after demonstration, and 1 week later to assess knowledge retention. RESULTS: In overall performance, the CBVI group demonstrated higher scores both in shave (3.54 vs 2.59, p = .01) and punch biopsies (3.63 vs 2.88, p = .01) at immediate recall and knowledge retention (3.68 vs 2.67, p = .01; 4.00 vs 2.99, p < .001, respectively). Approximately 33.3% of the students stated that the experience increased their interest in the field of dermatology. CONCLUSION: Incorporation of CBVI into the dermatology curriculum augments medical students' procedural skills. The CBVI group performed significantly better in all 7 grading categories for shave biopsy and in 5 of 7 categories for punch biopsy. Integration of procedural laboratory tests raises students' interest in dermatology.


Subject(s)
Biopsy/methods , Computer-Assisted Instruction/methods , Dermatologic Surgical Procedures/education , Dermatology/education , Education, Medical, Undergraduate/methods , Biopsy/standards , Cadaver , Clinical Competence , Computer-Assisted Instruction/standards , Curriculum , Dermatologic Surgical Procedures/standards , Dermatology/standards , Education, Medical, Undergraduate/standards , Humans , Pilot Projects , Single-Blind Method , Students, Medical
11.
J Am Acad Dermatol ; 79(5): 913-920.e1, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29920319

ABSTRACT

BACKGROUND: Granuloma annulare (GA) is a granulomatous skin eruption rarely associated with cancer. We report seven cases of paraneoplastic GA in association with solid organ malignancy. OBJECTIVE: To compare the clinical and histopathological features of paraneoplastic GA to case-matched controls of classic GA. METHODS: Retrospective chart and histopathological review of 7 individuals and 13 age- and sex-matched controls. Paraneoplastic GA was defined as GA occurring within 6 months of the diagnosis of solid organ malignancy and/or persistent GA that resolved with cancer treatment. RESULTS: Most cases of paraneoplastic GA were associated with lung cancer (4/7). The clinical and histopathological features of paraneoplastic and classic GA were similar. Compared to classic GA, paraneoplastic GA cases were more often generalized disease (6/7 vs 6/13), refractory to treatment, and had a perivascular inflammatory cell infiltrate (5/7 vs 2/13). All cases of paraneoplastic GA that underwent definitive treatment of their cancer improved. LIMITATIONS: Single-institution, retrospective review with a small sample size. CONCLUSION: Paraneoplastic GA is rare, similar to classic GA, and refractory to treatment. We advocate for age-appropriate screening in individuals with GA that is nonresponsive to multiple lines of systemic treatment and evaluating patients with concerning signs or symptoms for an underlying neoplasm.


Subject(s)
Cell Transformation, Neoplastic/pathology , Granuloma Annulare/epidemiology , Granuloma Annulare/pathology , Lung Neoplasms/epidemiology , Paraneoplastic Syndromes/pathology , Aged , Brain Neoplasms/epidemiology , Brain Neoplasms/pathology , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Case-Control Studies , Female , Glioblastoma/epidemiology , Glioblastoma/pathology , Glioblastoma/therapy , Humans , Incidence , Lung Neoplasms/pathology , Male , Melanoma/epidemiology , Melanoma/pathology , Melanoma/therapy , Middle Aged , Paraneoplastic Syndromes/epidemiology , Prognosis , Risk Assessment , Skin Neoplasms/epidemiology , Skin Neoplasms/pathology , Treatment Outcome
12.
J Cutan Pathol ; 45(5): 355-359, 2018 May.
Article in English | MEDLINE | ID: mdl-29405342

ABSTRACT

Despite well-defined clinical and histopathological features of melanoma, atypical presentations mimicking other skin disorders can result in a delayed diagnosis or misdiagnosis and subsequent inappropriate treatment. Rosai-Dorfman disease (RDD) is a rare histiocytic disorder with unique clinical and histopathological features. We report a case of melanoma treated with cryotherapy that mimicked RDD both clinically and histopathologically. We compare this RDD-like melanoma to classic RDD, outlining the importance of clinicopathological correlation prior to treatment, as well as the potential pitfalls in diagnosis after cryotherapy of pigmented lesions.


Subject(s)
Histiocytosis, Sinus/diagnosis , Melanoma/diagnosis , Skin Neoplasms/diagnosis , Aged , Diagnosis, Differential , Female , Histiocytosis, Sinus/pathology , Humans , Melanoma/pathology , Skin Neoplasms/pathology
13.
J Am Acad Dermatol ; 77(6): 1088-1095, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28964538

ABSTRACT

BACKGROUND: The ABCDE (with A standing for asymmetry, B for border irregularity, C for color variegation, D for diameter larger than 6 mm, and E for evolution) rule for melanoma (MM) recognition is widely taught in the general population. The ugly duckling (UD) sign is an alternate MM recognition strategy that is not generally taught. OBJECTIVE: To compare the sensitivity, specificity, and accuracy of MM recognition with UD sign and the ABCD rule in a general population. METHODS: Participants were randomized into either the ABCD or UD arm of the study. An educational tutorial on their respective teaching method followed. Participants were subsequently tested using images of 9 lesions (7 nevi and 2 MMs) and asked to categorize each image as MM or not MM. RESULTS: A total of 51 participants were randomized to the ABCD group and 50 to the UD group. The sensitivity for MM recognition of both groups was similar. The specificity and accuracy for MM recognition was significantly higher (P =.02, P = .02) in the UD group. LIMITATIONS: The E for evolution in the ABCDE rule was not tested. No follow-up knowledge retention test was conducted. CONCLUSION: The UD sign significantly improved accuracy and specificity of MM recognition. We recommend adding the UD sign to patient education in addition to the traditional ABCDE rule.


Subject(s)
Melanoma/pathology , Patient Education as Topic/methods , Skin Neoplasms/pathology , Adolescent , Adult , Aged , Child , Humans , Middle Aged , Reproducibility of Results , Sensitivity and Specificity , Young Adult
16.
Dermatol Surg ; 43(9): 1150-1156, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28445196

ABSTRACT

BACKGROUND: A realistic model for the instruction of basic dermatologic procedural skills was developed, while simultaneously increasing medical student exposure to the field of dermatology. OBJECTIVE: The primary purpose of the authors' study was to evaluate the utilization of a fresh-tissue cadaver model (FTCM) as a method for the instruction of common dermatologic procedures. The authors' secondary aim was to assess students' perceived clinical skills and overall perception of the field of dermatology after the lab. METHODS: Nineteen first- and second-year medical students were pre- and post-tested on their ability to perform punch and excisional biopsies on a fresh-tissue cadaver. Students were then surveyed on their experience. RESULTS: Assessment of the cognitive knowledge gain and technical skills revealed a statistically significant improvement in all categories (p < .001). An analysis of the survey demonstrated that 78.9% were more interested in selecting dermatology as a career and 63.2% of participants were more likely to refer their future patients to a Mohs surgeon. CONCLUSION: An FTCM is a viable method for the instruction and training of dermatologic procedures. In addition, the authors conclude that an FTCM provides realistic instruction for common dermatologic procedures and enhances medical students' early exposure and interest in the field of dermatology.


Subject(s)
Cadaver , Clinical Competence , Dermatology/education , Education, Medical/methods , Biopsy , Carcinoma, Basal Cell/pathology , Humans , Internship and Residency/methods , Melanoma/pathology , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL